{"id":86281,"date":"2020-04-27T19:11:11","date_gmt":"2020-04-27T13:41:11","guid":{"rendered":"https:\/\/apnlive.com\/?p=86281"},"modified":"2020-08-29T11:47:41","modified_gmt":"2020-08-29T06:17:41","slug":"hope-fop-corona-vaccine-brightens","status":"publish","type":"post","link":"https:\/\/apnlive.com\/latest-news\/hope-fop-corona-vaccine-brightens\/","title":{"rendered":"Hope fop a corona vaccine brightens"},"content":{"rendered":"<p>The <strong>Serum Institute of India<\/strong> will be <strong>manufacturing Oxford University&#8217;s coronavirus vaccine<\/strong> in anticipation of <strong>clinical trials<\/strong> succeeding by September-October in the UK. The company expressed optimism of starting trials in India for this vaccine over the next 2-3 weeks. The<strong> US clinical-stage synthetic biology company Codagenix<\/strong> has also entered into a collaboration with the<strong> Serum Institute of India<\/strong> to rapidly co-develop a live-attenuated vaccine against the <strong>emergent coronavirus<\/strong>.<\/p>\n<p>India is among the<strong> largest manufacturer of generic drugs<\/strong> and <strong>vaccines<\/strong> in the world. It is home to half a dozen major vaccine makers and a host of smaller ones, making doses against <strong>polio, meningitis, pneumonia, rotavirus, BCG, measles, mumps and rubella, among other diseases.<\/strong><\/p>\n<p>Now half a dozen Indian firms are developing vaccines against the virus that causes <strong>Covid-19<\/strong>. One of them is <strong>Serum Institute of India<\/strong>, the world&#8217;s largest vaccine maker by number of doses produced and sold globally. The 53-year-old company makes 1.5 billion doses every year, mainly from its two facilities in the western city of Pune. It has two other <strong>small plants<\/strong> in the <strong>Netherlands<\/strong> and the <strong>Czech Republic<\/strong>.<\/p>\n<p>The company supplies some 20 vaccines to 165 countries. Some 80% of its vaccines are exported and, at an average of 50 cents a dose, they are some of the cheapest in the world.<\/p>\n<p>Now the firm has stitched up collaboration with Codagenix, an American biotech company, to develop a &#8220;live attenuated&#8221; vaccine.<\/p>\n<p>This vaccine is created by reducing the virulence &#8211; or removing the harmful properties &#8211; of a pathogen but keeping it alive. The firm said it is planning a set of animal trials on mice and primates of this vaccine in April. By September, human trials will begin.<\/p>\n<p>The firm has also partnered to mass produce a vaccine for <strong>cororna virus<\/strong> being developed by the <strong>University of Oxford<\/strong> and backed by the UK government. A genetically engineered chimpanzee virus would form the basis for the new vaccine. Human clinical trials began in Oxford on Thursday. If all goes well, scientists hope to make at least a million doses by September. It&#8217;s pretty clear the world is going to need hundreds of millions of doses, ideally by the end of this year, to end this pandemic.<\/p>\n<p><strong>Global Covid-19 infections<\/strong> have already passed 2.5m with more than 177,000 deaths. <strong>Developing a safe vaccine<\/strong> which can be mass produced is going to be a time consuming exercise &#8211; every lot has to be chemically and biologically tested before being released.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>India is among the largest manufacturer of generic drugs and vaccines in the world. It is home to half a dozen major vaccine makers and a host of smaller ones, making doses against polio, meningitis, pneumonia, rotavirus, BCG, measles, mumps and rubella, among other diseases.<\/p>\n","protected":false},"author":4,"featured_media":86489,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_eb_attr":"","footnotes":"","jetpack_publicize_message":"","jetpack_is_tweetstorm":false,"jetpack_publicize_feature_enabled":true},"categories":[1497,17],"tags":[92143,96080,42,96078,96077,96079,92500,92476],"yst_prominent_words":[],"ppma_author":[140543],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/d2r2ijn7njrktv.cloudfront.net\/apnlive\/uploads\/2020\/05\/02204241\/WB.jpg","jetpack_sharing_enabled":true,"authors":[{"term_id":140543,"user_id":4,"is_guest":0,"slug":"apnnewsdesk","display_name":"APN Live","avatar_url":"https:\/\/secure.gravatar.com\/avatar\/478eacb893eda88aa6ed8d99b005bf58?s=96&r=g"}],"_links":{"self":[{"href":"https:\/\/apnlive.com\/wp-json\/wp\/v2\/posts\/86281"}],"collection":[{"href":"https:\/\/apnlive.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/apnlive.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/apnlive.com\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/apnlive.com\/wp-json\/wp\/v2\/comments?post=86281"}],"version-history":[{"count":0,"href":"https:\/\/apnlive.com\/wp-json\/wp\/v2\/posts\/86281\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/apnlive.com\/wp-json\/wp\/v2\/media\/86489"}],"wp:attachment":[{"href":"https:\/\/apnlive.com\/wp-json\/wp\/v2\/media?parent=86281"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/apnlive.com\/wp-json\/wp\/v2\/categories?post=86281"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/apnlive.com\/wp-json\/wp\/v2\/tags?post=86281"},{"taxonomy":"yst_prominent_words","embeddable":true,"href":"https:\/\/apnlive.com\/wp-json\/wp\/v2\/yst_prominent_words?post=86281"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/apnlive.com\/wp-json\/wp\/v2\/ppma_author?post=86281"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}<!-- html is corrupted -->